Viewing Study NCT02156895


Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2026-02-24 @ 3:16 PM
Study NCT ID: NCT02156895
Status: COMPLETED
Last Update Posted: 2024-03-08
First Post: 2014-05-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Korean PMS of Axitinib View
None Metastatic RCC ; 2nd line only View